Skip to content

Clinical Observation for Auricular Acupoint Stimulation combined with Low-concentration Atropine in Myopia Control

Clinical Observation for Acpuncture in Myopia Control

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021316
Enrollment
Unknown
Registered
2019-02-13
Start date
2019-04-01
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Group A:0.01% atropine eyedrops combined with auricular acupoint stimulation
Group B:0.01% atropine eyedrops

Sponsors

Eye & ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 7 to 12 years children, male or female, with simple myopia; 2. 0.5% tocarbamide mydriatic optometry: +0.5DS~-6.0DS; 3. Corneal power:41-46D; 4. Astigmatism of less than 1.50D, anisometropia of less than 1.50D, intraocular pressure of 10 to 21mmHg; 5. Patient with good compliance who volunteers to join the subject and signs informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient with other ocular diseases(e.g., cataract, congenital retinal disease, strabismus, amblyopia) or systemic diseases; 2. Patient with active eye lesions or undergo eye surgery; 3. Allergy to atropine; 4. Patient whose skin of the auricular acupoint area is broken or patient who has allergy to auricular plaster; 5. Guardians do not hold reasonable expectations.

Design outcomes

Primary

MeasureTime frame
Uncorrected distance visual acuity;Diopter;Axial length;

Secondary

MeasureTime frame
Anterior chamber depth;Accommodation amplitude;Accommodative microfluctuations;Choroid;

Contacts

Public ContactXingtao Zhou
xingtaozhou@163.com+86 13816880725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026